ERAVACYCLINE

ERAVACYCLINE was reported 298 times

ERAVACYCLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COAGULATION FACTOR LEVEL ABNORMAL 1 0.1667
1 HEPATIC HYPOPERFUSION 1 0.1429
2 DENTAL BONE GRAFT 1 0.0286
3 CATHETER SITE NECROSIS 1 0.0263
4 BLOOD FIBRINOGEN DECREASED 29 0.0254
5 PARAINFLUENZA VIRUS INFECTION 2 0.0194
6 CATHETER SITE PHLEBITIS 1 0.0192
7 PULMONARY BLASTOMYCOSIS 2 0.0174
8 SUSPECTED DRUG-INDUCED LIVER INJURY 3 0.0150
9 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 1 0.0145
10 DISSEMINATED BLASTOMYCOSIS 2 0.0117
11 VIRAL HEPATITIS CARRIER 1 0.0114
12 HYPOFIBRINOGENAEMIA 11 0.0111
13 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 2 0.0086
14 PASTEURELLA INFECTION 1 0.0078
15 PNEUMONIA ACINETOBACTER 1 0.0073
16 SERRATIA BACTERAEMIA 1 0.0068
17 PERIPANCREATIC FLUID COLLECTION 1 0.0066
18 BLASTOMYCOSIS 3 0.0062
19 PULMONARY MUCORMYCOSIS 3 0.0057
20 ACINETOBACTER TEST POSITIVE 1 0.0052
21 VOLVULUS OF SMALL BOWEL 1 0.0051
22 MYCOBACTERIUM TEST POSITIVE 1 0.0049
23 ACUTE ON CHRONIC LIVER FAILURE 1 0.0046
24 MYCOBACTERIUM ABSCESSUS INFECTION 3 0.0042
25 PERIPHERAL VEIN THROMBOSIS 1 0.0042
26 CALCIUM IONISED DECREASED 1 0.0041
27 INCISION SITE DISCHARGE 1 0.0040
28 DISEASE SUSCEPTIBILITY 1 0.0036
29 CATHETER SITE CELLULITIS 1 0.0034
30 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
31 COMPLICATIONS OF TRANSPLANTED LUNG 1 0.0033
32 HEPATIC ISCHAEMIA 1 0.0032
33 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
34 B-CELL TYPE ACUTE LEUKAEMIA 2 0.0027
35 PANCREATIC ENLARGEMENT 1 0.0027
36 HYDROURETER 1 0.0026
37 TRANSPLANTATION COMPLICATION 1 0.0024
38 PANCREATIC ENZYMES INCREASED 3 0.0020
39 ACINETOBACTER INFECTION 2 0.0018
40 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
41 HAEMATOMA INFECTION 1 0.0017
42 ANAL INFLAMMATION 1 0.0016
43 CUTANEOUS SYMPTOM 1 0.0015
44 ENTEROCOCCAL INFECTION 7 0.0014
45 HYPERTRANSAMINASAEMIA 10 0.0014
46 INFECTION PARASITIC 1 0.0013
47 URETERIC STENOSIS 1 0.0012
48 VASOSPASM 1 0.0011
49 PNEUMONIA KLEBSIELLA 2 0.0011
50 PROTHROMBIN LEVEL DECREASED 1 0.0011
51 HYPOPROTEINAEMIA 2 0.0011
52 BLOOD URINE 1 0.0010
53 PROTHROMBIN TIME PROLONGED 6 0.0010
54 PHLEBITIS 5 0.0010
55 CAROTID ARTERIOSCLEROSIS 1 0.0010
56 KLEBSIELLA SEPSIS 1 0.0009
57 MUCOSAL HAEMORRHAGE 1 0.0009
58 BILIRUBIN CONJUGATED INCREASED 2 0.0009
59 PROCALCITONIN INCREASED 1 0.0009
60 FEBRILE INFECTION 1 0.0008
61 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
62 INFUSION SITE EXTRAVASATION 5 0.0008
63 WHITE MATTER LESION 1 0.0008
64 TROPONIN T INCREASED 1 0.0008
65 SUBCUTANEOUS HAEMATOMA 1 0.0008
66 SLOW RESPONSE TO STIMULI 1 0.0008
67 ACQUIRED GENE MUTATION 1 0.0008
68 PNEUMONIA FUNGAL 3 0.0008
69 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
70 GASTRIC PERFORATION 2 0.0007
71 ISCHAEMIC HEPATITIS 1 0.0007
72 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
73 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
74 TRACHEOSTOMY 1 0.0007
75 TOOTH DISCOLOURATION 2 0.0007
76 PNEUMONIA PNEUMOCOCCAL 1 0.0007
77 BRAIN HERNIATION 2 0.0007
78 CRANIOCEREBRAL INJURY 2 0.0007
79 COAGULOPATHY 11 0.0007
80 PNEUMONIA PSEUDOMONAL 1 0.0007
81 METABOLIC ALKALOSIS 1 0.0006
82 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
83 ELECTROLYTE IMBALANCE 7 0.0006
84 ENTEROBACTER INFECTION 1 0.0006
85 SALMONELLOSIS 1 0.0006
86 GASTROINTESTINAL OEDEMA 1 0.0006
87 PATHOGEN RESISTANCE 5 0.0005
88 WOUND HAEMORRHAGE 2 0.0005
89 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
90 GENE MUTATION 1 0.0005
91 BLOOD ALBUMIN DECREASED 4 0.0005
92 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
93 CHOLANGITIS SCLEROSING 1 0.0005
94 BODY TEMPERATURE FLUCTUATION 1 0.0005
95 DISTRIBUTIVE SHOCK 1 0.0004
96 PANCREATITIS NECROTISING 1 0.0004
97 NEUROLOGICAL DECOMPENSATION 1 0.0004
98 THROMBOTIC MICROANGIOPATHY 4 0.0004
99 LIPASE INCREASED 3 0.0004
100 ABDOMINAL INFECTION 1 0.0004
101 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
102 DRUG TOLERANCE DECREASED 1 0.0004
103 OESOPHAGEAL STENOSIS 1 0.0004
104 RESPIRATORY SYMPTOM 1 0.0004
105 LACTIC ACIDOSIS 11 0.0003
106 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
107 BLOOD CULTURE POSITIVE 1 0.0003
108 EMBOLISM VENOUS 1 0.0003
109 CHEST X-RAY ABNORMAL 1 0.0003
110 DUODENITIS 1 0.0003
111 PORTAL HYPERTENSION 1 0.0003
112 MULTIPLE-DRUG RESISTANCE 1 0.0003
113 PORTAL VEIN THROMBOSIS 1 0.0003
114 BLOOD BILIRUBIN INCREASED 8 0.0003
115 HYPERBILIRUBINAEMIA 3 0.0003
116 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
117 LUNG TRANSPLANT 1 0.0003
118 FIBRIN D DIMER INCREASED 1 0.0003
119 SKIN WEEPING 1 0.0003
120 APPARENT DEATH 1 0.0003
121 RENAL TRANSPLANT 1 0.0003
122 AMYLASE INCREASED 1 0.0003
123 PROTEIN TOTAL DECREASED 1 0.0003
124 HYPOCALCAEMIA 5 0.0003
125 REHABILITATION THERAPY 1 0.0003
126 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
127 APNOEA 2 0.0003
128 PULMONARY HAEMORRHAGE 2 0.0003
129 OESOPHAGEAL CANDIDIASIS 1 0.0003
130 CEREBRAL ATROPHY 1 0.0003
131 EXTRAVASATION 1 0.0002
132 AORTIC DISSECTION 1 0.0002
133 DRUG RESISTANCE 6 0.0002
134 PULMONARY FUNCTION TEST DECREASED 1 0.0002
135 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
136 SUSPECTED OFF LABEL USE 1 0.0002
137 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
138 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
139 SHOCK 5 0.0002
140 PANCREATITIS 11 0.0002
141 PRESCRIBED OVERDOSE 4 0.0002
142 LIVER INJURY 5 0.0002
143 INFLAMMATORY MARKER INCREASED 1 0.0002
144 HEPATIC ENZYME ABNORMAL 1 0.0002
145 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
146 KLEBSIELLA INFECTION 1 0.0002
147 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
148 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
149 ENDOCARDITIS 1 0.0002
150 DRUG-INDUCED LIVER INJURY 6 0.0002
151 ANAL FISSURE 1 0.0002
152 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
153 TRANSAMINASES INCREASED 4 0.0002
154 MYOCARDIAL ISCHAEMIA 2 0.0002
155 PERICARDIAL EFFUSION 4 0.0002
156 BACTERAEMIA 2 0.0002
157 PIGMENTATION DISORDER 1 0.0002
158 THROMBOCYTOPENIA 18 0.0002
159 SEPTIC SHOCK 7 0.0002
160 MYDRIASIS 2 0.0002
161 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
162 ASPERGILLUS INFECTION 1 0.0002
163 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
164 PNEUMONITIS 4 0.0001
165 PARAESTHESIA ORAL 2 0.0001
166 ASCITES 4 0.0001
167 HAEMORRHAGE INTRACRANIAL 2 0.0001
168 HYDRONEPHROSIS 1 0.0001
169 PANCREATITIS ACUTE 3 0.0001
170 HEPATIC FAILURE 4 0.0001
171 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
172 HYPOALBUMINAEMIA 1 0.0001
173 PNEUMOTHORAX 2 0.0001
174 SHOCK HAEMORRHAGIC 1 0.0001
175 CEREBRAL INFARCTION 3 0.0001
176 POLYURIA 1 0.0001
177 PSEUDOMONAS INFECTION 1 0.0001
178 MYOPATHY 1 0.0001
179 SPINAL OSTEOARTHRITIS 1 0.0001
180 RESPIRATORY RATE INCREASED 1 0.0001
181 OFF LABEL USE 98 0.0001
182 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
183 PNEUMONIA BACTERIAL 1 0.0001
184 HEPATIC STEATOSIS 2 0.0001
185 HEPATIC ENCEPHALOPATHY 1 0.0001
186 SPUTUM DISCOLOURED 1 0.0001
187 GASTRIC ULCER 2 0.0001
188 DRUG INTOLERANCE 10 0.0001
189 SALIVARY HYPERSECRETION 1 0.0001
190 PLEURAL EFFUSION 6 0.0001
191 DRY THROAT 1 0.0001
192 SUBARACHNOID HAEMORRHAGE 1 0.0001
193 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
194 RENAL PAIN 1 0.0001
195 LIVER FUNCTION TEST INCREASED 2 0.0001
196 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
197 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
198 HEPATOTOXICITY 2 0.0001
199 MALNUTRITION 1 0.0001
200 NEPHROPATHY TOXIC 1 0.0001
201 HYPONATRAEMIA 5 0.0001
202 COMA 4 0.0001
203 CEREBRAL HAEMORRHAGE 3 0.0001
204 MYELOSUPPRESSION 3 0.0001
205 GENERALISED OEDEMA 1 0.0001
206 TOOTH EXTRACTION 1 0.0001
207 IMMUNE SYSTEM DISORDER 1 0.0001
208 PLATELET COUNT DECREASED 8 0.0001
209 ACUTE HEPATIC FAILURE 1 0.0001
210 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
211 MENTAL STATUS CHANGES 2 0.0001
212 OXYGEN SATURATION DECREASED 4 0.0001
213 BLOOD TEST ABNORMAL 1 0.0001
214 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
215 ACCIDENTAL UNDERDOSE 1 0.0001
216 RENAL INJURY 2 0.0001
217 IMMUNODEFICIENCY 1 0.0001
218 THERAPY NON-RESPONDER 3 0.0001
219 HYPOAESTHESIA ORAL 1 0.0001
220 TINNITUS 3 0.0001
221 SEPSIS 7 0.0001
222 ABSCESS 1 0.0001
223 SENSORY DISTURBANCE 1 0.0001
224 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
225 TREATMENT FAILURE 5 0.0001
226 CYTOMEGALOVIRUS INFECTION 1 0.0001
227 FUNGAL INFECTION 2 0.0001
228 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
229 CANDIDA INFECTION 1 0.0001
230 HEPATIC ENZYME INCREASED 4 0.0001
231 EOSINOPHILIA 1 0.0001
232 DRUG ERUPTION 1 0.0001
233 C-REACTIVE PROTEIN INCREASED 2 0.0001
234 RESPIRATORY FAILURE 4 0.0001
235 CONJUNCTIVITIS 1 0.0001
236 BACTERIAL INFECTION 1 0.0001
237 HEPATIC CIRRHOSIS 1 0.0001
238 CHOLESTASIS 1 0.0001
239 SEROTONIN SYNDROME 1 0.0001
240 PRODUCT PREPARATION ERROR 1 0.0000
241 PERITONITIS 1 0.0000
242 RHABDOMYOLYSIS 2 0.0000
243 RENAL IMPAIRMENT 4 0.0000
244 FAECES DISCOLOURED 1 0.0000
245 MENTAL DISORDER 2 0.0000
246 BLOOD CREATININE INCREASED 3 0.0000
247 PRODUCT PRESCRIBING ISSUE 1 0.0000
248 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
249 NEUROPATHY PERIPHERAL 4 0.0000
250 DISEASE RECURRENCE 2 0.0000
251 MENTAL IMPAIRMENT 1 0.0000
252 LUNG DISORDER 2 0.0000
253 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
254 EPISTAXIS 3 0.0000
255 CELLULITIS 2 0.0000
256 CONDITION AGGRAVATED 12 0.0000
257 HEPATITIS 1 0.0000
258 HAEMOGLOBIN DECREASED 4 0.0000
259 DEAFNESS 1 0.0000
260 RENAL FAILURE 5 0.0000
261 LIMB INJURY 1 0.0000
262 RED BLOOD CELL COUNT DECREASED 1 0.0000
263 RESPIRATORY DISORDER 1 0.0000
264 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
265 CORONARY ARTERY DISEASE 1 0.0000
266 DEEP VEIN THROMBOSIS 2 0.0000
267 SKIN DISORDER 1 0.0000
268 DELIRIUM 1 0.0000
269 UNDERDOSE 2 0.0000
270 ACCIDENTAL OVERDOSE 1 0.0000
271 HEPATIC FUNCTION ABNORMAL 1 0.0000
272 DYSPNOEA EXERTIONAL 1 0.0000
273 ANAEMIA 5 0.0000
274 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
275 DISORIENTATION 1 0.0000
276 DRUG INEFFECTIVE 33 0.0000
277 CARDIAC FAILURE 2 0.0000
278 NEUTROPHIL COUNT DECREASED 1 0.0000
279 OVERDOSE 5 0.0000
280 VAGINAL HAEMORRHAGE 1 0.0000
281 NEPHROLITHIASIS 1 0.0000
282 DIARRHOEA 14 0.0000
283 HYPOKALAEMIA 1 0.0000
284 ARRHYTHMIA 1 0.0000
285 PRODUCTIVE COUGH 1 0.0000
286 INFECTION 3 0.0000
287 HYPOAESTHESIA 3 0.0000
288 ILLNESS 2 0.0000
289 INFLAMMATION 1 0.0000
290 PARAESTHESIA 3 0.0000
291 NAUSEA 15 0.0000
292 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
293 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
294 OEDEMA 1 0.0000
295 ARTHROPATHY 1 0.0000
296 PANCYTOPENIA 1 0.0000
297 LETHARGY 1 0.0000
298 PYREXIA 6 0.0000
299 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
300 IRRITABILITY 1 0.0000
301 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
302 INJECTION SITE ERYTHEMA 2 0.0000
303 BLOOD PRESSURE DECREASED 1 0.0000
304 VOMITING 7 0.0000
305 NEUTROPENIA 2 0.0000
306 HALLUCINATION 1 0.0000
307 CHRONIC KIDNEY DISEASE 1 0.0000
308 ACUTE KIDNEY INJURY 2 0.0000
309 DRUG DOSE OMISSION BY DEVICE 1 0.0000
310 PNEUMONIA 4 0.0000
311 BALANCE DISORDER 1 0.0000
312 GASTROINTESTINAL DISORDER 1 0.0000
313 DEVICE ISSUE 1 0.0000
314 ADVERSE DRUG REACTION 1 0.0000
315 HYPERSENSITIVITY 2 0.0000
316 ATRIAL FIBRILLATION 1 0.0000
317 SOMNOLENCE 2 0.0000
318 CHEST DISCOMFORT 1 0.0000
319 ABDOMINAL PAIN UPPER 2 0.0000
320 ABDOMINAL DISTENSION 1 0.0000
321 RASH 4 0.0000
322 MUSCULAR WEAKNESS 1 0.0000
323 SEIZURE 1 0.0000
324 DECREASED APPETITE 2 0.0000
325 ABDOMINAL PAIN 2 0.0000
326 CHILLS 1 0.0000
327 OEDEMA PERIPHERAL 1 0.0000
328 DEATH 7 0.0000
329 VISUAL IMPAIRMENT 1 0.0000
330 INSOMNIA 2 0.0000
331 MEMORY IMPAIRMENT 1 0.0000
332 BLOOD PRESSURE INCREASED 1 0.0000
333 HOSPITALISATION 1 0.0000
334 HEADACHE 4 0.0000
335 DRUG INTERACTION 1 0.0000
336 DIZZINESS 3 0.0000
337 TOXICITY TO VARIOUS AGENTS 1 0.0000
338 URINARY TRACT INFECTION 1 0.0000
339 COVID-19 1 0.0000
340 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
341 CHEST PAIN 1 0.0000
342 PRODUCT USE ISSUE 1 0.0000
343 ASTHENIA 2 0.0000
344 DYSPNOEA 3 0.0000
345 GAIT DISTURBANCE 1 0.0000
346 HYPOTENSION 1 0.0000
347 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
348 HYPERTENSION 1 0.0000
349 COUGH 1 0.0000
350 PRODUCT DOSE OMISSION ISSUE 1 0.0000
351 MALAISE 1 0.0000
352 FATIGUE 1 0.0000